# Amgen's Biotech Investments: 19 Startups in Its Portfolio (2026) > The 19 Biotech startups Amgen has backed, by stage: $2.6B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/amgen-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series C and later 8 - [Kymera Therapeutics](https://millionrounds.com/company/kymera-therapeutics) - [Science 37](https://millionrounds.com/company/science-37) - [Obsidian Therapeutics](https://millionrounds.com/company/obsidian-therapeutics) - [*ST* SiteOne Therapeutics](https://millionrounds.com/company/siteone-therapeutics) - [*CP* Calistoga Pharmaceuticals](https://millionrounds.com/company/calistoga-pharmaceuticals) - [Akili](https://millionrounds.com/company/akili) - [Immatics](https://millionrounds.com/company/immatics) - [Syapse](https://millionrounds.com/company/syapse) ## Stage not reported 5 - [Epizyme](https://millionrounds.com/company/epizyme) - [*P* Precision](https://millionrounds.com/company/precision) - [Aetion](https://millionrounds.com/company/aetion) - [InteKrin](https://millionrounds.com/company/intekrin) - [*OC* Oncofactor Corporation](https://millionrounds.com/company/oncofactor-corporation) ## Series B 4 - [Senti Biosciences](https://millionrounds.com/company/senti-biosciences) - [QurAlis](https://millionrounds.com/company/quralis) - [*IB* Imago BioSciences](https://millionrounds.com/company/imago-biosciences) - [*A* Allozyne](https://millionrounds.com/company/allozyne) ## Series A 2 - [*VT* Viron Therapeutics](https://millionrounds.com/company/viron-therapeutics) - [*AT* Acylin Therapeutics](https://millionrounds.com/company/acylin-therapeutics) ## Segment by segment ### Series C and later 8 startups · $1.6B raised - [**Kymera Therapeutics**](https://millionrounds.com/company/kymera-therapeutics) Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation. United States $799M - [**Science 37**](https://millionrounds.com/company/science-37) Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers. United States $236M - [**Obsidian Therapeutics**](https://millionrounds.com/company/obsidian-therapeutics) Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy. United States $210M - [*ST* **SiteOne Therapeutics**](https://millionrounds.com/company/siteone-therapeutics) United States $119M - [*CP* **Calistoga Pharmaceuticals**](https://millionrounds.com/company/calistoga-pharmaceuticals) Calistoga Pharmaceuticals develops therapeutic oral medicines for patients suffering from cancer and inflammatory diseases. United States $97M - [**Akili**](https://millionrounds.com/company/akili) Akili is long Africa, permanent capital. United States $68M - [**Immatics**](https://millionrounds.com/company/immatics) Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with Germany $58M - [**Syapse**](https://millionrounds.com/company/syapse) Syapse is a real-world evidence company dedicated to extinguishing the fear and burden of serious disease by advancing real-world United States $45M ### Stage not reported 5 startups · $585M raised - [**Epizyme**](https://millionrounds.com/company/epizyme) Epizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors. United States $332M - [*P* **Precision**](https://millionrounds.com/company/precision) United States $111M - [**Aetion**](https://millionrounds.com/company/aetion) Aetion provides real-world evidence (RWE) and outcomes-based analytics solutions to life science companies and payers. United States $74M - [**InteKrin**](https://millionrounds.com/company/intekrin) InteKrin Therapeutics is focused on developing and commercializing therapeutics for neuroendocrine, metabolic and immune disorders. United States $65M - [*OC* **Oncofactor Corporation**](https://millionrounds.com/company/oncofactor-corporation) Oncofactor develops cancer therapeutics that disrupt signaling pathways between tumors and the immune system. United States $3.1M ### Series B 4 startups · $366M raised - [**Senti Biosciences**](https://millionrounds.com/company/senti-biosciences) Senti Biosciences is a biotechnology company that focuses on synthetic biology and gene circuit engineering for therapeutic applications. United States $169M - [**QurAlis**](https://millionrounds.com/company/quralis) QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD. United States $94M - [*IB* **Imago BioSciences**](https://millionrounds.com/company/imago-biosciences) Imago is a clinical stage biopharmaceutical company that develops drugs for the management of proliferative diseases of the bone marrow. United States $67M - [*A* **Allozyne**](https://millionrounds.com/company/allozyne) Allozyne develops technologies that improve the efficacy, safety, dosing, and other characteristics of protein-based therapeutics. United States $37M ### Series A 2 startups · $26M raised - [*VT* **Viron Therapeutics**](https://millionrounds.com/company/viron-therapeutics) Viron Therapeutics is a Biotechnology company Canada $20M - [*AT* **Acylin Therapeutics**](https://millionrounds.com/company/acylin-therapeutics) Acylin Therapeutics operates in the pharmaceutical and drug manufacturing industry developing inhibitors of cellular acetylation. United States $6.4M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Amgen as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Co-investors **Who invests with Amgen** 21 co-investors](https://millionrounds.com/portfolio-maps/amgen-co-investors)[Sector portfolio **Coinbase Ventures' Web3 & Crypto portfolio** 168 startups · $5.7B](https://millionrounds.com/portfolio-maps/coinbase-web3-crypto-portfolio)[Sector portfolio **Salesforce Ventures' AI portfolio** 115 startups · $181B](https://millionrounds.com/portfolio-maps/salesforce-ventures-ai-portfolio)[Sector portfolio **Google Ventures' AI portfolio** 81 startups · $16B](https://millionrounds.com/portfolio-maps/gv-ai-portfolio)[Sector portfolio **Google Ventures' Biotech portfolio** 74 startups · $12B](https://millionrounds.com/portfolio-maps/gv-biotech-portfolio)[Sector portfolio **Samsung Next's AI portfolio** 72 startups · $9.8B](https://millionrounds.com/portfolio-maps/samsung-next-ai-portfolio) ## Raising from investors like Amgen? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)